Migraine is a common chronic neurologic disease that may affect nearly 1 billion people worldwide. Serotonin 5-HT1B and 5-HT1D receptor agonists (triptans) have been the most widely prescribed acute migraine treatments for decades. However, some patients who use triptans either do not have a…
Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
Migraine is a common chronic neurologic disease that may affect nearly 1 billion people worldwide. Serotonin 5-HT1B and 5-HT1D receptor agonists (triptans) have been the most widely prescribed acute migraine treatments for decades. However, some patients who use triptans either do not have a…